Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Chronic Plaque Psoriasis

Explore clinical trials studying Moderate to Severe Chronic Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

17 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Moderate to Severe Chronic Plaque Psoriasis trial results

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

NCT06011733

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Ps0041 20023 Beijing, China
  • Ps0041 20247 Beijing, China
  • Ps0041 20306 Beijing, China
  • Ps0041 20117 Guangzhou, China
View all 18 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03536884

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Ps0015 975 Santa Ana, California, United States
  • Ps0015 939 Danbury, Connecticut, United States
  • Ps0015 903 Ocala, Florida, United States
  • Ps0015 921 Ormond Beach, Florida, United States
View all 77 locations
View Trial Details
Completed

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03410992

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Ps0013 919 San Diego, California, United States
  • Ps0013 955 San Diego, California, United States
  • Ps0013 967 Santa Monica, California, United States
  • Ps0013 928 Fort Myers, Florida, United States
View all 77 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03598790

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Ps0014 957 Glendale, Arizona, United States
  • Ps0014 946 Phoenix, Arizona, United States
  • Ps0014 910 Bakersfield, California, United States
  • Ps0014 927 Los Angeles, California, United States
View all 189 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03370133

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Ps0009 946 Phoenix, Arizona, United States
  • Ps0009 910 Bakersfield, California, United States
  • Ps0009 919 San Diego, California, United States
  • Ps0009 906 Boca Raton, Florida, United States
View all 105 locations
View Trial Details
Completed

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

NCT05388916

Conditions
Moderate to Severe Chronic Plaque Psoriasis
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Shenyang, Liaoning, China
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

NCT05975268

Conditions
Moderate to Severe Chronic Plaque Psoriasis
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
View all 63 locations
View Trial Details
Completed

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

NCT03766685

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Dv0002 946 Phoenix, Arizona, United States
  • Dv0002 910 Bakersfield, California, United States
  • Dv0002 955 San Diego, California, United States
  • Dv0002 943 San Luis Obispo, California, United States
View all 39 locations
View Trial Details

Related conditions